A Neuro-cognitive and Psychosocial Intervention Module in People With Epilepsy
Launched by POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH · Jul 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a special program designed to help people with drug-resistant epilepsy, which means their seizures don’t respond well to medication. The goal is to create and test a new set of strategies that focus on improving both thinking skills and emotional well-being. Researchers want to see if these strategies can make a difference in the lives of those living with epilepsy, especially since there's not much evidence about what works best in India. By developing a comprehensive approach that includes various assessment tools and interventions, the team hopes to better understand how to support patients, not just with medication, but also with tailored programs that address their specific needs.
To be eligible for this trial, participants need to be between 18 and 45 years old and should be willing to give their consent to take part. However, individuals with other neurological disorders, major psychiatric issues, or those who are pregnant or breastfeeding cannot participate. Those interested in joining can expect to engage in activities aimed at enhancing their cognitive and social skills, contributing to a better quality of life. This study is currently in the recruitment phase, and the results could help shape future support for people with epilepsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participants of 18 - 45 years of age.
- • 2. either gender
- • 3. Willing to participate and sign the informed consent
- Exclusion Criteria:
- • 1. Patients with other neurological disorders
- • 2. any other trial at inclusion
- • 3. should not have any major psychiatric disorder
- • 4. pregnant and lactating mothers
- • 5. also, patients who would not be giving informed consent
- • 6. Patients with intellectual disabilities.
About Post Graduate Institute Of Medical Education And Research, Chandigarh
The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh is a premier institute dedicated to advancing medical education, research, and healthcare delivery in India. Renowned for its commitment to excellence, PGIMER plays a pivotal role in conducting cutting-edge clinical trials that contribute to the development of innovative therapies and improve patient outcomes. With a multidisciplinary approach and a team of highly qualified professionals, PGIMER fosters a collaborative environment for research, aiming to enhance medical knowledge and practice through rigorous scientific inquiry and evidence-based solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chandigarh, , India
Patients applied
Trial Officials
Dr. Parampreet Singh Kharbanda, MD, DM
Study Chair
PGIMER, Chandigarh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported